Old Web
English
Sign In
Acemap
>
authorDetail
>
Joseph Dudash
Joseph Dudash
Johnson & Johnson Pharmaceutical Research and Development
Chemistry
Chemical synthesis
Biochemistry
Glycogen phosphorylase
Organic chemistry
5
Papers
164
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Synthesis and evaluation of 3-anilino-quinoxalinones as glycogen phosphorylase inhibitors.
2005
Bioorganic & Medicinal Chemistry Letters
Joseph Dudash
Yongzheng Zhang
John B. Moore
Richard Look
Yin Liang
Mary Pat Beavers
Bruce R. Conway
Philip J. Rybczynski
Keith T. Demarest
Show All
Source
Cite
Save
Citations (31)
Glycosylated dihydrochalcones as potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitors
2004
Bioorganic & Medicinal Chemistry Letters
Joseph Dudash
Xiaoyan Zhang
Roxanne E. Zeck
Sigmond G. Johnson
Geoffrey G. Cox
Bruce R. Conway
Philip J. Rybczynski
Keith T. Demarest
Show All
Source
Cite
Save
Citations (35)
Benzoxazinones as PPARgamma agonists. 2. SAR of the amide substituent and in vivo results in a type 2 diabetes model.
2004
Journal of Medicinal Chemistry
Philip J. Rybczynski
Roxanne E. Zeck
Joseph Dudash
Donald W. Combs
Thomas P. Burris
Maria Yang
Melville C. Osborne
Xiaoli Chen
Keith T. Demarest
Show All
Source
Cite
Save
Citations (47)
Derives de (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino)-benzamide et composes afferents comme inhibiteurs de la glycogene phosphorylase dans le traitement du diabete et de l'obesite
2004
Mary Pat Beavers
Joseph Dudash
Yongzheng Zhang
Show All
Source
Cite
Save
Citations (0)
1